Microvention-terumo, Inc.
Clinical trials sponsored by Microvention-terumo, Inc., explained in plain language.
-
Brain aneurysm device gets Long-Term safety check
Disease control OngoingThis study is tracking the long-term safety and effectiveness of the WEB device, which is already approved for treating wide-neck brain aneurysms. Researchers are following 195 adult patients for one year after their procedure to see how well the device seals off aneurysms and mo…
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:11 UTC
-
New brain stent aims to seal off dangerous bulges
Disease control OngoingThis study is comparing a newer version of a brain stent (called FRED X) to an older version. The goal is to see if the new device is just as safe and effective at sealing off a bulge in a brain artery (an aneurysm) to prevent it from rupturing. It will follow 154 people with a s…
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Feb 25, 2026 15:06 UTC
-
Massive study tracks 750 brain aneurysm patients to see if treatments hold up
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that collects real-world information on how well approved brain aneurysm treatment devices work over time. It will follow 750 patients who have already been scheduled to receive a specific company's device for a ruptured or unruptured brain aneurysm. The …
Sponsor: Microvention-Terumo, Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:20 UTC